MAD1 and its life as a MYC antagonist: An update

European Journal of Cell Biology

Volumn 91, Issue 6-7, 2012, Pages 506-514

  Lüscher, Bernhard ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Apoptosis; Chromatin; Cytokine; G CSF; Gene expression; Phosphorylation; Proliferation; TGF ; Tumor formation; Ubiquitination

Indexed keywords

HETERODIMER; MAX PROTEIN; MYC PROTEIN; PROTEIN MAD1;

APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; MAD1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPRESSOR GENE; SHORT SURVEY; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE PROTEINS; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84860258657     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.07.005     Document Type: Short Survey

References (102)

1. Abraham S., Sweet T., Khalili K., Sawaya B.E., Amini S. Evidence for activation of the TGF-beta1 promoter by C/EBPbeta and its modulation by Smads. J. Interferon Cytokine Res. 2009, 29:1-7.
2. Acosta J.C., Ferrandiz N., Bretones G., Torrano V., Blanco R., Richard C., O'Connell B., Sedivy J., Delgado M.D., Leon J. Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest. Mol. Cell. Biol. 2008, 28:7286-7295.
3. Ayer D.E., Eisenman R.N. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 1993, 7:2110-2119.
4. Ayer D.E., Kretzner L., Eisenman R.N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 1993, 72:211-222.
5. Ayer D.E., Lawrence Q.A., Eisenman R.N. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 1995, 80:767-776.
6. Basso K., Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv. Immunol. 2010, 105:193-210.
7. Bejarano M.T., Albihn A., Cornvik T., Brijker S.O., Asker C., Osorio L.M., Henriksson M. Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1. Exp. Cell Res. 2000, 260:61-72.
8. Berns K., Hijmans E.M., Bernards R. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 1997, 15:1347-1356.
9. Billin A.N., Eilers A.L., Queva C., Ayer D.E. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors. J. Biol. Chem. 1999, 274:36344-36350.
10. Blackwood E.M., Eisenman R.N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991, 251:1211-1217.
11. Blackwood E.M., Luscher B., Eisenman R.N. Myc and Max associate in vivo. Genes Dev. 1992, 6:71-80.
12. Bouchard C., Dittrich O., Kiermaier A., Dohmann K., Menkel A., Eilers M., Luscher B. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 2001, 15:2042-2047.
13. Briatore F., Barrera G., Pizzimenti S., Toaldo C., Casa C.D., Laurora S., Pettazzoni P., Dianzani M.U., Ferrero D. Increase of telomerase activity and hTERT expression in myelodysplastic syndromes. Cancer Biol. Ther. 2009, 8:883-889.
14. Chin L., Hahn W.C., Getz G., Meyerson M. Making sense of cancer genomic data. Genes Dev. 2011, 25:534-555.
15. Chou C.K., Lee D.F., Sun H.L., Li L.Y., Lin C.Y., Huang W.C., Hsu J.M., Kuo H.P., Yamaguchi H., Wang Y.N., Liu M., Wu H.Y., Liao P.C., Yen C.J., Hung M.C. The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription. Mol. Carcinog. 2009, 48:1048-1058.
16. Choy L., Derynck R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem. 2003, 278:9609-9619.
17. Cotter T.G. Apoptosis and cancer: the genesis of a research field. Nat. Rev. Cancer 2009, 9:501-507.
18. Crotty S., Johnston R.J., Schoenberger S.P. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat. Immunol. 2010, 11:114-120.
19. Cultraro C.M., Bino T., Segal S. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol. Cell. Biol. 1997, 17:2353-2359.
20. Dai Z., Zhu W.G., Morrison C.D., Brena R.M., Smiraglia D.J., Raval A., Wu Y.Z., Rush L.J., Ross P., Molina J.R., Otterson G.A., Plass C. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum. Mol. Genet. 2003, 12:791-801.
21. Dang C.V. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 2010, 70:859-862.
22. Descargues P., Sil A.K., Sano Y., Korchynskyi O., Han G., Owens P., Wang X.J., Karin M. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2487-2492.
23. Di Cristofano A., Pandolfi P.P. The multiple roles of PTEN in tumor suppression. Cell 2000, 100:387-390.
24. Eilers M., Eisenman R.N. Myc's broad reach. Genes Dev. 2008, 22:2755-2766.
25. Foley K.P., McArthur G.A., Queva C., Hurlin P.J., Soriano P., Eisenman R.N. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 1998, 17:774-785.
26. Fox E.J., Wright S.C. S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells. Biochem. J. 2001, 359:361-367.
27. Ge Z., Li W., Wang N., Liu C., Zhu Q., Bjorkholm M., Gruber A., Xu D. Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. FASEB J. 2010, 24:579-586.
28. Gehring S., Rottmann S., Menkel A.R., Mertsching J., Krippner-Heidenreich A., Luscher B. Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1. Repression of Fas-induced caspase-8 activation. J. Biol. Chem. 2000, 275:10413-10420.
29. Guo X.L., Pan L., Zhang X.J., Suo X.H., Niu Z.Y., Zhang J.Y., Wang F., Dong Z.R., Da W., Ohno R. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia. Leukemia Lymphoma 2007, 48:1200-1207.
30. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
31. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 1997, 89:341-347.
32. Hein N., Jiang K., Cornelissen C., Luscher B. TGFbeta1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: basic functions of C/EBP, SP and SMAD3 transcription factors. BMC Mol. Biol. 2011, 12:9.
33. Henriksson M., Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 1996, 68:109-182.
34. Hurlin P.J., Huang J. The MAX-interacting transcription factor network. Semin. Cancer Biol. 2006, 16:265-274.
35. Hurlin P.J., Queva C., Eisenman R.N. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 1997, 11:44-58.
36. Hurlin P.J., Queva C., Koskinen P.J., Steingrimsson E., Ayer D.E., Copeland N.G., Jenkins N.A., Eisenman R.N. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 1995, 14:5646-5659.
37. Hurlin P.J., Steingrimsson E., Copeland N.G., Jenkins N.A., Eisenman R.N. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J. 1999, 18:7019-7028.
38. Hurlin P.J., Zhou Z.Q., Toyo-Oka K., Ota S., Walker W.L., Hirotsune S., Wynshaw-Boris A. Evidence of mnt-myc antagonism revealed by mnt gene deletion. Cell Cycle 2004, 3:97-99.
39. Huynh K.M., Soh J.W., Dash R., Sarkar D., Fisher P.B., Kang D. FOXM1 expression mediates growth suppression during terminal differentiation of HO-1 human metastatic melanoma cells. J. Cell Physiol. 2011, 226:194-204.
40. Imoto I., Yang Z.Q., Pimkhaokham A., Tsuda H., Shimada Y., Imamura M., Ohki M., Inazawa J. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res. 2001, 61:6629-6634.
41. Iritani B.M., Delrow J., Grandori C., Gomez I., Klacking M., Carlos L.S., Eisenman R.N. Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J. 2002, 21:4820-4830.
42. James L., Eisenman R.N. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:10429-10434.
43. Jiang K., Hein N., Eckert K., Luscher-Firzlaff J., Luscher B. Regulation of the MAD1 promoter by G-CSF. Nucleic Acids Res. 2008, 36:1517-1531.
44. Kim D., Chung J. Akt: versatile mediator of cell survival and beyond. J. Biochem. Mol. Biol. 2002, 35:106-115.
45. Klapproth K., Wirth T. Advances in the understanding of MYC-induced lymphomagenesis. Br. J. Haematol. 2010, 149:484-497.
46. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
47. Kouzarides T., Ziff E. The role of the leucine zipper in the fos-jun interaction. Nature 1988, 336:646-651.
48. Kretzner L., Blackwood E.M., Eisenman R.N. Myc and Max proteins possess distinct transcriptional activities. Nature. 1992, 359:426-429.
49. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 1997, 89:349-356.
50. Landschulz W.H., Johnson P.F., McKnight S.L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 1988, 240:1759-1764.
51. Laoukili J., Stahl M., Medema R.H. FoxM1: at the crossroads of ageing and cancer. Biochim. Biophys. Acta 2007, 1975:92-102.
52. Larsson L.G., Bahram F., Burkhardt H., Luscher B. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene 1997, 15:737-748.
53. Larsson L.G., Pettersson M., Oberg F., Nilsson K., Luscher B. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 1994, 9:1247-1252.
54. Lassar A.B., Buskin J.N., Lockshon D., Davis R.L., Apone S., Hauschka S.D., Weintraub H. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 1989, 58:823-831.
55. Lee L.A., Dang C.V. Myc target transcriptomes. Curr. Top. Microbiol. Immunol. 2006, 302:145-167.
56. Lee S.C., Bottaro A., Chen L., Insel R.A. Mad1 is a transcriptional repressor of Bcl-6. Mol. Immunol. 2006, 43:1965-1971.
57. Lin C.J., Cencic R., Mills J.R., Robert F., Pelletier J. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res. 2008, 68:5326-5334.
58. Lin Y., Wong K., Calame K. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997, 276:596-599.
59. Liu J., Levens D. Making myc. Curr. Top. Microbiol. Immunol. 2006, 302:1-32.
60. Luscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 2001, 277:1-14.
61. Luscher B., Eisenman R.N. New light on Myc and Myb Part I. Myc. Genes Dev. 1990, 4:2025-2035.
62. Luscher B., Larsson L.G. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 1999, 18:2955-2966.
63. Luscher-Firzlaff J.M., Lilischkis R., Luscher B. Regulation of the transcription factor FOXM1c by Cyclin E/CDK2. FEBS Lett. 2006, 580:1716-1722.
64. Luscher-Firzlaff J.M., Westendorf J.M., Zwicker J., Burkhardt H., Henriksson M., Muller R., Pirollet F., Luscher B. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene 1999, 18:5620-5630.
65. Lutz W., Leon J., Eilers M. Contributions of Myc to tumorigenesis. Biochim. Biophys. Acta 2003, 1602:61-71.
66. Meroni G., Cairo S., Merla G., Messali S., Brent R., Ballabio A., Reymond A. Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?. Oncogene 2000, 19:3266-3277.
67. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
68. Murre C., McCaw P.S., Vaessin H., Caudy M., Jan L.Y., Jan Y.N., Cabrera C.V., Buskin J.N., Hauschka S.D., Lassar A.B., et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 1989, 58:537-544.
69. Nikiforov M.A., Popov N., Kotenko I., Henriksson M., Cole M.D. The Mad and Myc basic domains are functionally equivalent. J. Biol. Chem. 2003, 278:11094-11099.
70. Nilsson J.A., Maclean K.H., Keller U.B., Pendeville H., Baudino T.A., Cleveland J.L. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol. Cell. Biol. 2004, 24:1560-1569.
71. Ovcharenko I., Nobrega M.A., Loots G.G., Stubbs L. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res. 2004, 32:W280-W286.
72. Pearce L.R., Komander D., Alessi D.R. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 2010, 11:9-22.
73. Petrov V.V., van Pelt J.F., Vermeesch J.R., Van Duppen V.J., Vekemans K., Fagard R.H., Lijnen P.J. TGF-beta1-induced cardiac myofibroblasts are nonproliferating functional cells carrying DNA damages. Exp. Cell Res. 2008, 314:1480-1494.
74. Pirity M., Blanck J.K., Schreiber-Agus N. Lessons learned from Myc/Max/Mad knockout mice. Curr. Top. Microbiol. Immunol. 2006, 302:205-234.
75. Pulverer B., Sommer A., McArthur G.A., Eisenman R.N., Luscher B. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. J. Cell Physiol. 2000, 183:399-410.
76. Rama S., Suresh Y., Rao A.J. TGF beta1 induces multiple independent signals to regulate human trophoblastic differentiation: mechanistic insights. Mol. Cell Endocrinol. 2003, 206:123-136.
77. Rottmann S., Luscher B. The mad side of the Max network: antagonizing the function of Myc and more. Curr. Top. Microbiol. Immunol. 2006, 302:63-122.
78. Rottmann S., Menkel A.R., Bouchard C., Mertsching J., Loidl P., Kremmer E., Eilers M., Luscher-Firzlaff J., Lilischkis R., Luscher B. Mad1 function in cell proliferation and transcriptional repression is antagonized by cyclin E/CDK2. J. Biol. Chem. 2005, 280:15489-15492.
79. Rottmann S., Speckgens S., Luscher-Firzlaff J., Luscher B. Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene. FASEB J. 2008, 22:1124-1134.
80. Sassone-Corsi P., Ransone L.J., Lamph W.W., Verma I.M. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature 1988, 336:692-695.
81. Secombe J., Li L., Carlos L., Eisenman R.N. The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev. 2007, 21:537-551.
82. Sloan E.J., Ayer D.E. Myc, Mondo, and metabolism. Genes Cancer 2010, 1:587-596.
83. Sommer A., Bousset K., Kremmer E., Austen M., Luscher B. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J. Biol. Chem. 1998, 273:6632-6642.
84. Sommer A., Hilfenhaus S., Menkel A., Kremmer E., Seiser C., Loidl P., Luscher B. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr. Biol. 1997, 7:357-365.
85. Sommer A., Waha A., Tonn J., Sorensen N., Hurlin P.J., Eisenman R.N., Luscher B., Pietsch T. Analysis of the Max-binding protein MNT in human medulloblastomas. Int. J. Cancer 1999, 82:810-816.
86. Stewart S.A., Weinberg R.A. Telomeres: cancer to human aging. Annu. Rev. Cell Dev. Biol. 2006, 22:531-557.
87. Touw I.P., van de Geijn G.J. Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders. Front. Biosci. 2007, 12:800-815.
88. van Riggelen J., Yetil A., Felsher D.W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer. 2010, 10:301-309.
89. Vervoorts J., Luscher B. Post-translational regulation of the tumor suppressor p27(KIP1). Cell Mol. Life Sci. 2008, 65:3255-3264.
90. Vervoorts J., Luscher-Firzlaff J., Luscher B. The ins and outs of MYC regulation by posttranslational mechanisms. J. Biol. Chem. 2006, 281:34725-34729.
91. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2:489-501.
92. Wang H.B., Wang X.W., Zhou G., Wang W.Q., Sun Y.G., Yang S.M., Fang D.C. PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway. J. Gastrointest. Surg. 2010, 14:1227-1234.
93. Weake V.M., Workman J.L. Inducible gene expression: diverse regulatory mechanisms. Nat. Rev. Genet. 2010, 11:426-437.
94. Werner S., Beer H.D., Mauch C., Luscher B., Werner S. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis. Oncogene 2001, 20:7494-7504.
95. Wu S., Hultquist A., Hydbring P., Cetinkaya C., Oberg F., Larsson L.G. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity. Exp. Cell Res. 2009, 315:3099-3111.
96. Xu D., Popov N., Hou M., Wang Q., Bjorkholm M., Gruber A., Menkel A.R., Henriksson M. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3826-3831.
97. Xu L., Zhu J., Hu X., Zhu H., Kim H.T., LaBaer J., Goldberg A., Yuan J. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Mol. Cell 2007, 28:914-922.
98. Yang L., Han Y., Suarez Saiz F., Minden M.D. A tumor suppressor and oncogene: the WT1 story. Leukemia 2007, 21:868-876.
99. Zender L., Spector M.S., Xue W., Flemming P., Cordon-Cardo C., Silke J., Fan S.T., Luk J.M., Wigler M., Hannon G.J., Mu D., Lucito R., Powers S., Lowe S.W. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125:1253-1267.
100. Zervos A.S., Gyuris J., Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 1993, 72:223-232.
101. Zhu J., Blenis J., Yuan J. Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6584-6589.
102. Zimmermann J., Erdmann D., Lalande I., Grossenbacher R., Noorani M., Furst P. Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1. Oncogene 2000, 19:2913-2920.